KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $5.7 billion.

  • Pfizer's Shares Outstanding (Weighted Average) rose 31.76% to $5.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 31.76%. This contributed to the annual value of $5.7 billion for FY2024, which is 37.21% up from last year.
  • As of Q3 2025, Pfizer's Shares Outstanding (Weighted Average) stood at $5.7 billion, which was up 31.76% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Shares Outstanding (Weighted Average) registered a high of $5.7 billion during Q2 2025, and its lowest value of $5.6 billion during Q2 2021.
  • For the 5-year period, Pfizer's Shares Outstanding (Weighted Average) averaged around $5.6 billion, with its median value being $5.6 billion (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 93.58% in 2021, then fell by 3.57% in 2022.
  • Pfizer's Shares Outstanding (Weighted Average) (Quarter) stood at $5.6 billion in 2021, then grew by 0.12% to $5.6 billion in 2022, then grew by 0.62% to $5.6 billion in 2023, then rose by 0.37% to $5.7 billion in 2024, then grew by 0.37% to $5.7 billion in 2025.
  • Its Shares Outstanding (Weighted Average) was $5.7 billion in Q3 2025, compared to $5.7 billion in Q2 2025 and $5.7 billion in Q1 2025.